{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T04:16:07Z","timestamp":1774412167800,"version":"3.50.1"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology - Research and Practice"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.prp.2022.153859","type":"journal-article","created":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T02:00:46Z","timestamp":1648519246000},"page":"153859","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Clinico-pathologic characteristics and prognostic factors of ovarian carcinoma with different histologic subtypes - A benchmark analysis of 482 cases"],"prefix":"10.1016","volume":"233","author":[{"given":"Christine E.","family":"Brambs","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne Kathrin","family":"H\u00f6hn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabine","family":"Klagges","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Albrecht","family":"Gl\u00e4ser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabine","family":"Taubenheim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nadja","family":"Dornh\u00f6fer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jens","family":"Einenkel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gesine Grit Ruth","family":"Hiller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lars-Christian","family":"Horn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"28","key":"10.1016\/j.prp.2022.153859_bib1","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1038\/s41571-020-0378-y","article-title":"The changing landscape of cancer in the USA - opportunities for advancing prevention and treatment","author":"Islami","year":"2020","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.prp.2022.153859_bib2","unstructured":"RKI (2020). Robert Koch Institute. https:\/\/www.krebsdaten.de\/Krebs\/DE\/Content\/Publikationen\/Krebs_in_Deutschland\/kid_2019\/kid_2019_c56_eierstoecke.pdf?__blob=publicationFile, (Accessed 31 August 2020)."},{"issue":"11","key":"10.1016\/j.prp.2022.153859_bib3","doi-asserted-by":"crossref","first-page":"287","DOI":"10.2147\/IJWH.S197604","article-title":"Ovarian cancer in the world: epidemiology and risk factors","volume":"Apr 30","author":"Momenimovahed","year":"2019","journal-title":"Int J. Women\u2019s. Health"},{"issue":"cco","key":"10.1016\/j.prp.2022.153859_bib4","first-page":"20","article-title":"Epidemiology of ovarian cancer","volume":"Jun 30","author":"Gaona-Luviano","year":"2020","journal-title":"Chin. Clin. Oncol."},{"key":"10.1016\/j.prp.2022.153859_bib5","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.humpath.2018.06.018","article-title":"Ovarian carcinomas: at least five different diseases with distinct histological features and molecular genetics","volume":"80","author":"Prat","year":"2018","journal-title":"Hum. Pathol."},{"issue":"1","key":"10.1016\/j.prp.2022.153859_bib6","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/nrc.2016.113","article-title":"The disparate origins of ovarian cancers: pathogenesis and prevention strategies","volume":"17","author":"Karnezis","year":"2017","journal-title":"Nat. Rev. Cancer"},{"issue":"4","key":"10.1016\/j.prp.2022.153859_bib7","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.ajpath.2015.11.011","article-title":"The dualistic model of ovarian carcinogenesis: revisited, revised, and expanded","volume":"186","author":"Kurman","year":"2016","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.prp.2022.153859_bib8","article-title":"Back to the Future? The Fallopian Tube, Precursor Escape and a Dualistic Model of High-Grade Serous Carcinogenesis","volume":"10","author":"Soong","year":"2018"},{"issue":"8","key":"10.1016\/j.prp.2022.153859_bib9","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1038\/modpathol.2015.77","article-title":"International collaboration on cancer reporting. Data set for reporting of ovary, fallopian tube and primary peritoneal carcinoma: recommendations from the International Collaboration on Cancer Reporting (ICCR)","volume":"28","author":"McCluggage","year":"2015","journal-title":"Mod. Pathol."},{"issue":"2","key":"10.1016\/j.prp.2022.153859_bib10","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.ygyno.2015.10.022","article-title":"Primary site assignment in tubo-ovarian high-grade serous carcinoma: Consensus statement on unifying practice worldwide","volume":"141","author":"Singh","year":"2016","journal-title":"Gynecol. Oncol."},{"issue":"38","key":"10.1016\/j.prp.2022.153859_bib11","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1097\/PGP.0000000000000552","article-title":"Endometrial carcinoma, grossing and processing issues: recommendations of the international society of gynecologic pathologists","volume":"Suppl 1","author":"Malpica","year":"2019","journal-title":"Int J. Gynecol. Pathol."},{"issue":"9","key":"10.1016\/j.prp.2022.153859_bib12","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1056\/NEJMoa1808424","article-title":"A randomized trial of lymphadenectomy in patients with advanced ovarian neoplasms","volume":"380","author":"Harter","year":"2019","journal-title":"N. Engl. J. Med"},{"issue":"4","key":"10.1016\/j.prp.2022.153859_bib13","first-page":"284","article-title":"Ovarian cancer statistics, 2018","volume":"68","author":"Torre","year":"2018","journal-title":"CA Cancer J. Clin."},{"issue":"10","key":"10.1016\/j.prp.2022.153859_bib14","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1111\/aogs.12948","article-title":"Ovarian and tubal cancer in Denmark: an update on incidence and survival","volume":"95","author":"Gottschau","year":"2016","journal-title":"Acta Obstet. Gynecol. Scand."},{"issue":"9","key":"10.1016\/j.prp.2022.153859_bib15","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1007\/s00432-017-2422-6","article-title":"Cancer of the ovary, fallopian tube, and peritoneum: a population-based comparison of the prognostic factors and outcomes","volume":"143","author":"Rottmann","year":"2017","journal-title":"J. Cancer Res Clin. Oncol."},{"issue":"1","key":"10.1016\/j.prp.2022.153859_bib16","first-page":"7","article-title":"Cancer statistics, 2020","volume":"70","author":"Siegel","year":"2020","journal-title":"CA Cancer J. Clin."},{"issue":"2","key":"10.1016\/j.prp.2022.153859_bib17","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.ygyno.2018.01.030","article-title":"Trends in the incidence of serous fallopian tube, ovarian, and peritoneal cancer in the US","volume":"149","author":"Liao","year":"2018","journal-title":"Gynecol. Oncol."},{"issue":"3","key":"10.1016\/j.prp.2022.153859_bib18","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.ygyno.2016.06.023","article-title":"Serous ovarian and primary peritoneal cancers: a comparative analysis of clinico-pathological features, molecular subtypes and treatment outcome","volume":"142","author":"Gao","year":"2016","journal-title":"Gynecol. Oncol."},{"issue":"2","key":"10.1016\/j.prp.2022.153859_bib19","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.ygyno.2016.11.019","article-title":"Worldwide comparison of ovarian cancer survival: Histological group and stage at diagnosis (CONCORD-2)","volume":"144","author":"Matz","year":"2017","journal-title":"Gynecol. Oncol."},{"issue":"9972","key":"10.1016\/j.prp.2022.153859_bib20","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/S0140-6736(14)62038-9","article-title":"Global surveillance of cancer survival 1995-2009: analysis of individual data for 25,676,887 patients from 279 population-based registries in 67 countries (CONCORD-2)","volume":"385","author":"Allemani","year":"2015","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.prp.2022.153859_bib21","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1097\/01.pgp.0000101080.35393.16","article-title":"The histologic type and stage distribution of ovarian carcinomas of surface epithelial origin","volume":"23","author":"Seidman","year":"2004","journal-title":"Int. Jourgao B serous Perit. Gynecol. Pathol."},{"issue":"4","key":"10.1016\/j.prp.2022.153859_bib22","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2015-010123","article-title":"Predictors of mortality within 1 year after primary ovarian cancer surgery: a nationwide cohort study","volume":"6","author":"\u00d8rskov","year":"2016","journal-title":"BMJ Open"},{"issue":"8","key":"10.1016\/j.prp.2022.153859_bib23","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1007\/s00432-015-1945-y","article-title":"The prognostic relevance of node metastases in optimally cytoreduced advanced ovarian cancer","volume":"141","author":"Bachmann","year":"2015","journal-title":"J. Cancer Res Clin. Oncol."},{"issue":"5","key":"10.1016\/j.prp.2022.153859_bib24","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1097\/PGP.0000000000000274","article-title":"An immunohistochemical algorithm for ovarian carcinoma typing","volume":"35","author":"K\u00f6bel","year":"2016","journal-title":"Int J. Gynecol. Pathol."},{"issue":"4","key":"10.1016\/j.prp.2022.153859_bib25","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1097\/PGP.0000000000000530","article-title":"Ovarian carcinoma histotype: strengths and limitations of integrating morphology with immunohistochemical predictions","volume":"38","author":"K\u00f6bel","year":"2019","journal-title":"Int J. Gynecol. Pathol."},{"issue":"3","key":"10.1016\/j.prp.2022.153859_bib26","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1097\/PGP.0000000000000251","article-title":"Calibration and optimization of p53, WT1, and napsin A immunohistochemistry ancillary tests for histotyping of ovarian carcinoma: canadian immunohistochemistry quality control (CIQC) experience","volume":"35","author":"Lee","year":"2016","journal-title":"Int J. Gynecol. Pathol."},{"issue":"4","key":"10.1016\/j.prp.2022.153859_bib27","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1097\/PGP.0000000000000342","article-title":"Value of pathology review in a population-based series of ovarian tumors","volume":"36","author":"Stewart","year":"2017","journal-title":"Int J. Gynecol. Pathol."},{"issue":"10","key":"10.1016\/j.prp.2022.153859_bib28","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1200\/JCO.2009.25.3617","article-title":"Potential role of lymphadenectomy in advanced ovarian cancer: a combined exploratory analysis of three prospectively randomized phase III multicenter trials","volume":"28","author":"du Bois","year":"2010","journal-title":"J. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.prp.2022.153859_bib29","first-page":"161","article-title":"Histologic subtypes of ovarian carcinoma: an overview","volume":"27","author":"Soslow","year":"2008","journal-title":"Int J. Gynecol. Pathol."},{"issue":"1","key":"10.1016\/j.prp.2022.153859_bib30","doi-asserted-by":"crossref","first-page":"39","DOI":"10.5858\/arpa.2014-0057-RA","article-title":"The utility of immunohistochemistry in the differential diagnosis of gynecologic disorders","volume":"139","author":"Kaspar","year":"2015","journal-title":"Arch. Pathol. Lab Med"}],"container-title":["Pathology - Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033822001029?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033822001029?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T03:33:57Z","timestamp":1774409637000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0344033822001029"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":30,"alternative-id":["S0344033822001029"],"URL":"https:\/\/doi.org\/10.1016\/j.prp.2022.153859","relation":{},"ISSN":["0344-0338"],"issn-type":[{"value":"0344-0338","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinico-pathologic characteristics and prognostic factors of ovarian carcinoma with different histologic subtypes - A benchmark analysis of 482 cases","name":"articletitle","label":"Article Title"},{"value":"Pathology - Research and Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prp.2022.153859","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier GmbH. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"153859"}}